Clovis Oncology Inc (Clovis Oncology Inc (CLVS)) is higher by Thursday morning, with the stock rising 7.81% in pre-market trading to 8.56.
CLVS's short-term technical score of 81 indicates that the stock has traded more bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 108 out of 146 industries, the stock ranks higher than 84% of stocks.
Clovis Oncology Inc has risen 71.12% over the past month, closing at $4.80 on December 31. During this period of time, the stock fell as low as $4.80 and as high as $9.55. CLVS has an average analyst recommendation of Sell. The company has an average price target of $7.25.
Clovis Oncology Inc has a Long-Term Technical rank of 16. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 84% of the market scoring higher. In the Biotechnology industry which is number 92 by this metric, CLVS ranks better than 31% of stocks.
Important Dates for Investors in CLVS:
-Clovis Oncology Inc is set to release earnings on 2/22/2021. During their last earnings release the company posted EPS of $-5.24. -We do not have a set dividend date for Clovis Oncology Inc at this time. Click Here to get the full Stock Score Report on Clovis Oncology Inc (CLVS) Stock.